In-vitro Toxicology Market : Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00$ 8,900.00

In-vitro Toxicology Market: By Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging, OMICS Technology), By Method (Cellular Assay, Biochemical Assay, In Silico, Ex-vivo), By Application (Systemic Toxicology, Dermal Toxicity, Endocrine Disruption, Ocular Toxicity, Others), By End-user (Pharmaceutical Industry, Cosmetics & Household Products, Diagnostics, Chemicals Industry, Food Industry) and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

The In-vitro Toxicology Market size was valued at USD 10.2 billion in 2021 and is expected to reach a value of USD 21.2 billion by 2028, growing at a CAGR of 11.1% during the forecast period 2022 to 2028. The global market report provides a detailed overview of the In-vitro Toxicology Market, which has been segmented by technology, method, application, and end-user. The in-vitro toxicology market has been segmented by technology into Cell Culture Technology, High Throughput Technology, Molecular Imaging, and OMICS Technology. The Cell Culture Technology segment is likely the largest and fastest growing in terms of technology. This method has segmented the in-vitro toxicology market into Cellular Assay, Biochemical Assay, In Silico, and Ex-vivo. The Cellular Assay segment will gain the maximum revenue share over the forecast period. The in-vitro toxicology market has been segmented into Systemic Toxicology, Dermal Toxicity, Endocrine Disruption, Ocular Toxicity, and Others. The Dermal Toxicity segment is expected to account for the high revenue share in 2022-2028. Based on end-user, the in-vitro toxicology is segmented into Pharmaceutical Industry, Cosmetics & Household Products, Diagnostics, Chemicals Industry, and Food Industry. According to precision business insights, the Chemicals Industry segment is predicted to register the fastest growth rate during the forecast period.

Key Development:

In March 2022, Laboratory Corporation of America Holdings acquired AtlantiCare diagnostic’s clinical laboratory services.

In-vitro Toxicology Market

MARKET SUMMARY
-
11.1%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 11.1%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

In-vitro Toxicology Market

  • The in-vitro toxicology market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The in-vitro toxicology market report gives historical, current, and future market sizes (US$ Mn) based on  by technology, by method, application, end user and geography.
Key Players
  • Charles River
  • Catalent, Inc.
  • Eurofins Scientific
  • Creative Bioarray
  • Quest Diagnostics Incorporated
In-vitro Toxicology Market Drivers

An increase in the number of R&D activities that require in vitro testing, a restriction on animal testing, and increased awareness about environmental concerns are the factors driving the global in vitro toxicology testing market, which is likely to develop significantly throughout the forecast period.


North-America Got Significant Share

In-vitro Toxicology Market

The North American market is expected to witness the highest market share during the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The in-vitro toxicology market report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The in-vitro toxicology market report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The in-vitro toxicology market report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The in-vitro toxicology market report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The in-vitro toxicology market report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
In-vitro Toxicology Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The in-vitro toxicology market is projected to expand at a CAGR of 11.1% during the forecast period.

The major players in the global In-vitro Toxicology market are ​​​ Agilent Technologies, Inc., Abbott, Beckman Coulter, Inc., Merck KGaA, Dassault Systèmes, GENERAL ELECTRIC COMPANY, Quest Diagnostics Incorporated, Labcorp Drug Development, Thermo Fisher Scientific Inc., Catalent, Inc., Charles River Laboratories International, Inc.

North America is the fastest-growing region for in-vitro toxicology market


Report

Table Of Content

1. Executive Summary
2. Global In-vitro Toxicology Market Introduction
2.1. Global In-vitro Toxicology Market – Taxonomy
2.2. Global In-vitro Toxicology Market –Definitions
2.2.1. By Technology
2.2.2. By Method
2.2.3. By Application
3. Global In-vitro Toxicology Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global In-vitro Toxicology Market Dynamic Factors – Impact Analysis
4. Global In-vitro Toxicology Market Analysis,2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis,2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global In-vitro Toxicology Market, By Technology, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. Cell Culture Technology
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. High Throughput Technology
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Molecular Imaging
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. OMICS Technology
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global In-vitro Toxicology Market Forecast, By Method, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1. Cellular Assay
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Biochemical Assay
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. In Silico
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Ex-vivo
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global In-vitro Toxicology Market Forecast, By Application, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1. Systemic Toxicology
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Dermal Toxicity
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Endocrine Disruption
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Ocular Toxicity
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Others
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. Global In-vitro Toxicology Market Forecast, By End-user, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. Pharmaceutical Industry
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Cosmetics & Household Products
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Diagnostics
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Chemicals Industry
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Food Industry
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
9. Global In-vitro Toxicology Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global In-vitro Toxicology Market – Opportunity Analysis Index, By Technology, By Method, By Application, End-user and Region, 2022 – 2028
10. North America In-vitro ToxicologyMarketAnalysis,2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Cell Culture Technology
10.1.2. High Throughput Technology
10.1.3. Molecular Imaging
10.1.4. OMICS Technology
10.2. Method Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Cellular Assay
10.2.2. Biochemical Assay
10.2.3. In Silico
10.2.4. Ex-vivo
10.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Systemic Toxicology
10.3.2. Dermal Toxicity
10.3.3. Endocrine Disruption
10.3.4. Ocular Toxicity
10.3.5. Others
10.4. End-user Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Pharmaceutical Industry
10.4.2. Cosmetics & Household Products
10.4.3. Diagnostics
10.4.4. Chemicals Industry
10.4.5. Food Industry
10.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America In-vitro Toxicology Market – Opportunity Analysis Index, By Technology, By Method, By Application and Country, 2022 – 2028
10.7. North America In-vitro Toxicology Market Dynamics – Trends
11. Europe In-vitro Toxicology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Cell Culture Technology
11.1.2. High Throughput Technology
11.1.3. Molecular Imaging
11.1.4. OMICS Technology
11.2. Method Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Cellular Assay
11.2.2. Biochemical Assay
11.2.3. In Silico
11.2.4. Ex-vivo
11.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Systemic Toxicology
11.3.2. Dermal Toxicity
11.3.3. Endocrine Disruption
11.3.4. Ocular Toxicity
11.3.5. Others
11.4. End-user Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Pharmaceutical Industry
11.4.2. Cosmetics & Household Products
11.4.3. Diagnostics
11.4.4. Chemicals Industry
11.4.5. Food Industry
11.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe In-vitro Toxicology Market – Opportunity Analysis Index, By Technology, By Method, By Application and Country,2022 – 2028
11.7. Europe In-vitro Toxicology Market Dynamics – Trends
12. Asia-Pacific In-vitro Toxicology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Cell Culture Technology
12.1.2. High Throughput Technology
12.1.3. Molecular Imaging
12.1.4. OMICS Technology
12.2. Method Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Cellular Assay
12.2.2. Biochemical Assay
12.2.3. In Silico
12.2.4. Ex-vivo
12.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Systemic Toxicology
12.3.2. Dermal Toxicity
12.3.3. Endocrine Disruption
12.3.4. Ocular Toxicity
12.3.5. Others
12.4. End-user Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Pharmaceutical Industry
12.4.2. Cosmetics & Household Products
12.4.3. Diagnostics
12.4.4. Chemicals Industry
12.4.5. Food Industry
12.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific In-vitro Toxicology Market – Opportunity Analysis Index, By Technology, By Method, By Application and Country,2022 – 2028
12.7. Asia-Pacific In-vitro Toxicology Market Dynamics – Trends
13. Latin America In-vitro Toxicology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
13.1. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
13.1.1. Cell Culture Technology
13.1.2. High Throughput Technology
13.1.3. Molecular Imaging
13.1.4. OMICS Technology
13.2. Method Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Cellular Assay
13.2.2. Biochemical Assay
13.2.3. In Silico
13.2.4. Ex-vivo
13.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Systemic Toxicology
13.3.2. Dermal Toxicity
13.3.3. Endocrine Disruption
13.3.4. Ocular Toxicity
13.3.5. Others
13.4. End-user Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Pharmaceutical Industry
13.4.2. Cosmetics & Household Products
13.4.3. Diagnostics
13.4.4. Chemicals Industry
13.4.5. Food Industry
13.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Rest of Latin America
13.6. Latin America In-vitro Toxicology Market – Opportunity Analysis Index, By Technology, By Method, By Application and Country,2022 – 2028
13.7. Latin America In-vitro Toxicology Market Dynamics – Trends
14. Middle East and Africa In-vitro Toxicology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
14.1. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
14.1.1. Cell Culture Technology
14.1.2. High Throughput Technology
14.1.3. Molecular Imaging
14.1.4. OMICS Technology
14.2. Method Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Cellular Assay
14.2.2. Biochemical Assay
14.2.3. In Silico
14.2.4. Ex-vivo
14.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Systemic Toxicology
14.3.2. Dermal Toxicity
14.3.3. Endocrine Disruption
14.3.4. Ocular Toxicity
14.3.5. Others
14.4. End-user Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Pharmaceutical Industry
14.4.2. Cosmetics & Household Products
14.4.3. Diagnostics
14.4.4. Chemicals Industry
14.4.5. Food Industry
14.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA In-vitro Toxicology Market – Opportunity Analysis Index, By Technology, By Method, By Application and Country,2022 – 2028
14.7. MEA In-vitro Toxicology Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Method& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Charles River
15.2.2. Catalent, Inc.
15.2.3. Eurofins Scientific
15.2.4. Quest Diagnostics Incorporated
15.2.5. Laboratory Corporation of America Holdings
15.2.6. Evotec
15.2.7. Creative Bioarray
15.2.8. Gentronix
15.2.9. HD Biosciences Co., Ltd.
15.2.10. MB Research Laboratories
15.2.11. BioIVT
15.2.12. SGS SA
15.2.13. GVK Biosciences Private Limited
15.2.14. InSphero
16. Research Methodology
17. Key Assumptions and Acronyms

 


Report

Company Profile

  • Charles River
  • Catalent, Inc.
  • Eurofins Scientific
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings
  • Evotec
  • Creative Bioarray
  • Gentronix
  • HD Biosciences Co., Ltd.
  • MB Research Laboratories
  • BioIVT
  • SGS SA
  • GVK Biosciences Private Limited
  • InSphero

Description

The In-vitro Toxicology Market size was valued at USD 10.2 billion in 2021 and is expected to reach a value of USD 21.2 billion by 2028, growing at a CAGR of 11.1% during the forecast period 2022 to 2028. The global market report provides a detailed overview of the In-vitro Toxicology Market, which has been segmented by technology, method, application, and end-user. The in-vitro toxicology market has been segmented by technology into Cell Culture Technology, High Throughput Technology, Molecular Imaging, and OMICS Technology. The Cell Culture Technology segment is likely the largest and fastest growing in terms of technology. This method has segmented the in-vitro toxicology market into Cellular Assay, Biochemical Assay, In Silico, and Ex-vivo. The Cellular Assay segment will gain the maximum revenue share over the forecast period. The in-vitro toxicology market has been segmented into Systemic Toxicology, Dermal Toxicity, Endocrine Disruption, Ocular Toxicity, and Others. The Dermal Toxicity segment is expected to account for the high revenue share in 2022-2028. Based on end-user, the in-vitro toxicology is segmented into Pharmaceutical Industry, Cosmetics & Household Products, Diagnostics, Chemicals Industry, and Food Industry. According to precision business insights, the Chemicals Industry segment is predicted to register the fastest growth rate during the forecast period.

Key Development:

In March 2022, Laboratory Corporation of America Holdings acquired AtlantiCare diagnostic’s clinical laboratory services.

Reviews

There are no reviews yet.

Be the first to review “In-vitro Toxicology Market : Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX